Overview of techniques involved (e.g. 'omics')

For stratified and personalised medicine to develop, we need to understand the underlying biology of health, disease and response to treatment. They can improve the efficiency of clinical trials and offer potential new targets for new medicines.

Biomarkers are indicators of normal or disease processes in the body that can be measured. This might include an individual’s response to a medicine.

Progress in this area helps develop new targeted treatments and tests that can predict the risk and/or course of disease.